↓ Skip to main content

PLOS

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Overview of attention for article published in PLOS ONE, April 2010
Altmetric Badge

Readers on

mendeley
593 Mendeley
citeulike
5 CiteULike
Title
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
Published in
PLOS ONE, April 2010
DOI 10.1371/journal.pone.0009979
Pubmed ID
Authors

Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale Bredesen, Arlan Richardson, Randy Strong, Veronica Galvan

Abstract

Reduced TOR signaling has been shown to significantly increase lifespan in a variety of organisms [1], [2], [3], [4]. It was recently demonstrated that long-term treatment with rapamycin, an inhibitor of the mTOR pathway[5], or ablation of the mTOR target p70S6K[6] extends lifespan in mice, possibly by delaying aging. Whether inhibition of the mTOR pathway would delay or prevent age-associated disease such as AD remained to be determined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 593 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 6 1%
United States 2 <1%
Netherlands 1 <1%
Australia 1 <1%
Brazil 1 <1%
Ireland 1 <1%
India 1 <1%
Singapore 1 <1%
Iran, Islamic Republic of 1 <1%
Other 5 <1%
Unknown 573 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 137 23%
Researcher 103 17%
Student > Bachelor 83 14%
Student > Master 62 10%
Student > Doctoral Student 25 4%
Other 82 14%
Unknown 101 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 163 27%
Biochemistry, Genetics and Molecular Biology 103 17%
Neuroscience 77 13%
Medicine and Dentistry 53 9%
Pharmacology, Toxicology and Pharmaceutical Science 23 4%
Other 58 10%
Unknown 116 20%